These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1559 related articles for article (PubMed ID: 18646476)

  • 1. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with more than 500 minimally invasive hepatic procedures.
    Buell JF; Thomas MT; Rudich S; Marvin M; Nagubandi R; Ravindra KV; Brock G; McMasters KM
    Ann Surg; 2008 Sep; 248(3):475-86. PubMed ID: 18791368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transdiaphragmatic radiofrequency ablation of malignant liver tumors].
    Takeda Y; Hasuike Y; Kashiwazaki M; Shin E; Tsujinaka T
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2229-33. PubMed ID: 12484043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of liver resection in combination with radiofrequency ablation for hepatic malignancies.
    Eisele RM; Zhukowa J; Chopra S; Schmidt SC; Neumann U; Pratschke J; Schumacher G
    Eur J Surg Oncol; 2010 Mar; 36(3):269-74. PubMed ID: 19726155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival after radiofrequency ablation of complex unresectable liver tumors.
    Amersi FF; McElrath-Garza A; Ahmad A; Zogakis T; Allegra DP; Krasne R; Bilchik AJ
    Arch Surg; 2006 Jun; 141(6):581-7; discussion 587-8. PubMed ID: 16785359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
    Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis.
    Abitabile P; Hartl U; Lange J; Maurer CA
    Eur J Surg Oncol; 2007 Feb; 33(1):67-71. PubMed ID: 17174059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radio-frequency ablation in cirrhotic patients with hepatocellular carcinoma.
    Arch-Ferrer JE; Smith JK; Bynon S; Eckhoff DE; Sellers MT; Bland KI; Heslin MJ
    Am Surg; 2003 Dec; 69(12):1067-71. PubMed ID: 14700292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
    Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
    Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
    Raut CP; Izzo F; Marra P; Ellis LM; Vauthey JN; Cremona F; Vallone P; Mastro A; Fornage BD; Curley SA
    Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
    Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
    Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre.
    Lam CM; Ng KK; Poon RT; Ai V; Yuen J; Fan ST
    Br J Surg; 2004 Mar; 91(3):334-8. PubMed ID: 14991635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.
    Elias D; De Baere T; Smayra T; Ouellet JF; Roche A; Lasser P
    Br J Surg; 2002 Jun; 89(6):752-6. PubMed ID: 12027986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence.
    Ayav A; Germain A; Marchal F; Tierris I; Laurent V; Bazin C; Yuan Y; Robert L; Brunaud L; Bresler L
    Am J Surg; 2010 Oct; 200(4):435-9. PubMed ID: 20409524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer.
    Kornprat P; Jarnagin WR; DeMatteo RP; Fong Y; Blumgart LH; D'Angelica M
    Arch Surg; 2007 Nov; 142(11):1087-92. PubMed ID: 18025338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.